University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Consensus Statements on PSMA PET/CT Response Assessment Criteria in Prostate Cancer

Simple item page
dc.contributor.authorFanti, Stefano
dc.contributor.authorGoffin, Karolien
dc.contributor.authorHadaschik, Boris A
dc.contributor.authorHerrmann, Ken
dc.contributor.authorMaurer, Tobias
dc.contributor.authorMacLennan, Steven
dc.contributor.authorOprea-Lage, Daniela E.
dc.contributor.authorOyen, Wim JG
dc.contributor.authorRouvière, Olivier
dc.contributor.authorMottet, Nicolas
dc.contributor.authorBjartell, Anders
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Academic Urology Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2021-02-23T21:22:01Z
dc.date.available2021-02-23T21:22:01Z
dc.date.issued2021-02
dc.descriptionFunding The one-day EAU / EANM PSMA PET/CT Response Assessment Criteria meeting received an unrestricted grant from Janssen, and no influences on the content of the meeting or on the publication. Acknowledgements The authors acknowledge John William Bean PhD (Bean Medical Writing, Halle, Belgium and funded by EAU Research Foundation) for providing medical writing services and Wim Witjes MD PhD (Scientific and Clinical Research Director EAU Research Foundation) and Emily Spieker (Management Assistant, European Association of Urology) for project management.en
dc.description.statusPeer revieweden
dc.format.extent8
dc.format.extent292517
dc.identifier171197370
dc.identifier4859a567-604e-405d-a3da-2d3912eab9f8
dc.identifier32617640
dc.identifier000545056400001
dc.identifier85087447530
dc.identifier.citationFanti, S, Goffin, K, Hadaschik, B A, Herrmann, K, Maurer, T, MacLennan, S, Oprea-Lage, D E, Oyen, W JG, Rouvière, O, Mottet, N & Bjartell, A 2021, 'Consensus Statements on PSMA PET/CT Response Assessment Criteria in Prostate Cancer', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 2, pp. 469–476. https://doi.org/10.1007/s00259-020-04934-4en
dc.identifier.doi10.1007/s00259-020-04934-4
dc.identifier.iss2en
dc.identifier.issn1619-7070
dc.identifier.otherORCID: 0000-0002-2691-8421
dc.identifier.otherORCID: 0000-0002-5761-3786
dc.identifier.otherORCID: /0000-0002-2691-8421/work/79061768
dc.identifier.urihttps://hdl.handle.net/2164/15912
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85087447530&partnerID=8YFLogxKen
dc.identifier.vol48en
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imagingen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectMonitoringen
dc.subjectOligometastatic Prostate Canceren
dc.subjectPERCISTen
dc.subjectPolymetastatic Prostate Canceren
dc.subjectProstate Canceren
dc.subjectProstate-Specific Membrane Antigen (PSMA)en
dc.subjectPSMA Liganden
dc.subjectRECISTen
dc.subjectPET/CTen
dc.subjectR Medicine (General)en
dc.subjectRadiology Nuclear Medicine and imagingen
dc.subject.lccR1en
dc.titleConsensus Statements on PSMA PET/CT Response Assessment Criteria in Prostate Canceren
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Fanti_etal_Consensus_Statements_VOR.pdf
Size:
285.66 KB
Format:
Adobe Portable Document Format
Download

Collections

All research